Nyxoah (NYXH) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Nyxoah SA, a medical technology company, has raised $27 million by selling 3 million shares in an on-the-market offering, with the support of a new American healthcare investor. This financial boost aims to strengthen the company’s focus on the U.S. market, following encouraging data from their DREAM pivotal study and preparations for the U.S. launch of their Genio system for obstructive sleep apnea treatment. Nyxoah’s Genio device, already CE marked in Europe, is making strides towards FDA approval and U.S. commercialization.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
